These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 36969562)
1. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis. Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562 [No Abstract] [Full Text] [Related]
2. Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer. Guo Q; Liu XL; Jiang N; Zhang WJ; Guo SW; Yang H; Ji YM; Zhou J; Guo JL; Zhang J; Liu HS Am J Cancer Res; 2022; 12(11):4904-4929. PubMed ID: 36504892 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
5. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers. Jin D; Yuan L; Li F; Wang S; Mao Y BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma. Hu D; Zhang M; Peng Z J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma. Li X; Xiao X; Chang R; Zhang C J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983 [TBL] [Abstract][Full Text] [Related]
8. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer. Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371 [TBL] [Abstract][Full Text] [Related]
9. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data. Li D; Deng W; Huang G; Xiao X Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339 [TBL] [Abstract][Full Text] [Related]
10. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma. Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390 [TBL] [Abstract][Full Text] [Related]
11. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance. Xiao H; Xu Y Med Sci Monit; 2021 Feb; 27():e929347. PubMed ID: 33591959 [TBL] [Abstract][Full Text] [Related]
13. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma. Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599 [No Abstract] [Full Text] [Related]
14. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
15. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
16. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma. Wu K; Zhang C; Zhang C; Dai D Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment. Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230 [TBL] [Abstract][Full Text] [Related]
18. SYNGR2 serves as a prognostic biomarker and correlates with immune infiltrates in esophageal squamous cell carcinoma. Li B; Ren MY; Chen YZ; Meng YQ; Song TN; Su ZP; Yang B J Gene Med; 2022 Aug; 24(8):e3441. PubMed ID: 35840542 [TBL] [Abstract][Full Text] [Related]
19. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
20. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma. Ma C; Luo H Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]